Cow's Milk Allergy

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

J&
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
Amino Acid formulaN/A1 trial
Active Trials
NCT01584245Terminated32Est. Jul 2014
Abbott
AbbottABBOTT PARK, IL
1 program
Experimental Extensively Hydrolyzed FormulaN/A1 trial
Active Trials
NCT04910373Terminated1Est. Feb 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AbbottExperimental Extensively Hydrolyzed Formula
Johnson & JohnsonAmino Acid formula

Clinical Trials (2)

Total enrollment: 33 patients across 2 trials

NCT04910373AbbottExperimental Extensively Hydrolyzed Formula

Extensively Hydrolyzed Infant Formula in Infants and Children With Cow's Milk Allergy

Start: Jan 2022Est. completion: Feb 20221 patients
N/ATerminated

Evaluation of the Efficacy of an Amino Acid Based Formula in Infants

Start: Feb 2012Est. completion: Jul 201432 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space